Rhythm management in atrial fibrillation—with a primary emphasis on pharmacological therapy: Part 2
C Costeas, J Kassotis, M Blitzer… - Pacing and clinical …, 1998 - Wiley Online Library
Atrial fibrillation (AF) is the most common, sustained, symptomatic tachyarrhythmia that
clinicians are called upon to manage. Management strategies include ventricular rate
control coupled with anticoagulation, versus restoration and maintenance of sinus rhythm.
Rate control may be achieved pharmacologically, with agents that impair AV nodal
conduction directly and/or by increasing parasympathetic/sympathetic balance, or by
modifying or ablating the AV nodal region anatomically. Rhythm control may be achieved by …
clinicians are called upon to manage. Management strategies include ventricular rate
control coupled with anticoagulation, versus restoration and maintenance of sinus rhythm.
Rate control may be achieved pharmacologically, with agents that impair AV nodal
conduction directly and/or by increasing parasympathetic/sympathetic balance, or by
modifying or ablating the AV nodal region anatomically. Rhythm control may be achieved by …
Rhythm management in atrial fibrillation—with a primary emphasis on pharmacological therapy: Part 1
M Blitzer, C Costeas, J Kassotis… - Pacing and clinical …, 1998 - Wiley Online Library
Atrial fibrillation (AF) is the most common, sustained, symptomatic tachyarrhythmia that
clinicians are called upon to manage. Management strategies include ventricular rate
control coupled with anticoagulation, versus restoration and maintenance of sinus rhythm.
Rate control may be achieved pharmacologically, with agents that impair AV nodal
conduction directly and/or by increasing parasympathetic/sympathetic balance, or by
modifying or ablating the AV nodal region anatomically. Rhythm control may be achieved by …
clinicians are called upon to manage. Management strategies include ventricular rate
control coupled with anticoagulation, versus restoration and maintenance of sinus rhythm.
Rate control may be achieved pharmacologically, with agents that impair AV nodal
conduction directly and/or by increasing parasympathetic/sympathetic balance, or by
modifying or ablating the AV nodal region anatomically. Rhythm control may be achieved by …